circACVR2A competitively sponged miR-1290 and was exerted as a tumor suppressor gene oncogene via a circACVR2A/miR-1290 axis, suggesting it as a possible biomarker for GC therapy.
CircRNA ACVR2A Sponges miR-1290 to Modulate Cell Progression in Gastric Cancer.